These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34548517)

  • 1. Exploring reward-related attention selectivity deficits in Parkinson's disease.
    Pilgrim MJD; Ou ZA; Sharp M
    Sci Rep; 2021 Sep; 11(1):18751. PubMed ID: 34548517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine is associated with prioritization of reward-associated memories in Parkinson's disease.
    Sharp ME; Duncan K; Foerde K; Shohamy D
    Brain; 2020 Aug; 143(8):2519-2531. PubMed ID: 32844197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine selectively remediates 'model-based' reward learning: a computational approach.
    Sharp ME; Foerde K; Daw ND; Shohamy D
    Brain; 2016 Feb; 139(Pt 2):355-64. PubMed ID: 26685155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease.
    Hälbig TD; Assuras S; Creighton J; Borod JC; Tse W; Frisina PG; Voustianiouk A; Gracies JM; Olanow CW
    Mov Disord; 2011 Aug; 26(9):1677-83. PubMed ID: 21638322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
    Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
    Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
    Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
    Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition.
    Rowe JB; Hughes L; Ghosh BC; Eckstein D; Williams-Gray CH; Fallon S; Barker RA; Owen AM
    Brain; 2008 Aug; 131(Pt 8):2094-105. PubMed ID: 18577547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine restores cognitive motivation in Parkinson's disease.
    McGuigan S; Zhou SH; Brosnan MB; Thyagarajan D; Bellgrove MA; Chong TT
    Brain; 2019 Mar; 142(3):719-732. PubMed ID: 30689734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine enhances willingness to exert effort for reward in Parkinson's disease.
    Chong TT; Bonnelle V; Manohar S; Veromann KR; Muhammed K; Tofaris GK; Hu M; Husain M
    Cortex; 2015 Aug; 69():40-6. PubMed ID: 25967086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
    Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
    Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of asymmetric dopamine depletion on sensitivity to rewarding and aversive stimuli in Parkinson's disease.
    Maril S; Hassin-Baer S; Cohen OS; Tomer R
    Neuropsychologia; 2013 Apr; 51(5):818-24. PubMed ID: 23422331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease.
    Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M
    J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivational modulation of bradykinesia in Parkinson's disease off and on dopaminergic medication.
    Kojovic M; Mir P; Trender-Gerhard I; Schneider SA; Pareés I; Edwards MJ; Bhatia KP; Jahanshahi M
    J Neurol; 2014 Jun; 261(6):1080-9. PubMed ID: 24687892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learning to be inflexible: Enhanced attentional biases in Parkinson's disease.
    Fallon SJ; Hampshire A; Barker RA; Owen AM
    Cortex; 2016 Sep; 82():24-34. PubMed ID: 27318659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism.
    Moustafa AA; Sherman SJ; Frank MJ
    Neuropsychologia; 2008 Nov; 46(13):3144-56. PubMed ID: 18687347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.
    Evens R; Hoefler M; Biber K; Lueken U
    Neuropsychologia; 2016 Oct; 91():163-172. PubMed ID: 27475264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?
    van Eimeren T; Ballanger B; Pellecchia G; Miyasaki JM; Lang AE; Strafella AP
    Neuropsychopharmacology; 2009 Dec; 34(13):2758-66. PubMed ID: 19741594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic medication increases motivation to exert cognitive control by reducing subjective effort costs in Parkinson's patients.
    Bogdanov M; LoParco S; Otto AR; Sharp M
    Neurobiol Learn Mem; 2022 Sep; 193():107652. PubMed ID: 35724812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic medication alters auditory distractor processing in Parkinson's disease.
    Georgiev D; Jahanshahi M; Dreo J; Čuš A; Pirtošek Z; Repovš G
    Acta Psychol (Amst); 2015 Mar; 156():45-56. PubMed ID: 25697781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.